Su1873 RESULTS FROM AN OPEN-LABEL STUDY (ECOSPOR IV) TO EVALUATE THE SAFETY AND EFFICACY OF SER-109, AN INVESTIGATIONAL ORAL MICROBIOME THERAPEUTIC, IN ADULTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (RCDI): A SUBGROUP ANALYSIS